HUTCHMED DRC Financials
| HCM Stock | USD 17.41 0.05 0.29% |
Operating Margin (0.09) | Profit Margin (0.07) | Short Ratio 4.27 | EPS Estimate Current Year (0.23) | Return On Equity (0.05) |
HUTCHMED |
Understanding current and past HUTCHMED DRC Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of HUTCHMED DRC's financial statements are interrelated, with each one affecting the others. For example, an increase in HUTCHMED DRC's assets may result in an increase in income on the income statement.
HUTCHMED DRC Stock Summary
HUTCHMED DRC competes with Capricor Therapeutics, Soleno Therapeutics, Bio Path, Moleculin Biotech, and Crinetics Pharmaceuticals. HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchmed China operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 2110 people.| Foreign Associate | UK |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US44842L1035 |
| CUSIP | 44842L103 |
| Location | Hong Kong |
| Business Address | Cheung Kong Center, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.hutch-med.com |
| Phone | 852 2121 8200 |
| Currency | USD - US Dollar |
HUTCHMED DRC Key Financial Ratios
| Return On Equity | -0.0544 | ||||
| Return On Asset | -0.059 | ||||
| Target Price | 28.53 | ||||
| Beta | 0.75 |
HUTCHMED Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining HUTCHMED DRC's current stock value. Our valuation model uses many indicators to compare HUTCHMED DRC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HUTCHMED DRC competition to find correlations between indicators driving HUTCHMED DRC's intrinsic value. More Info.HUTCHMED DRC is one of the top stocks in return on equity category among its peers. It is rated # 2 in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value HUTCHMED DRC by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.HUTCHMED DRC Systematic Risk
HUTCHMED DRC's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. HUTCHMED DRC volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on HUTCHMED DRC correlated with the market. If Beta is less than 0 HUTCHMED DRC generally moves in the opposite direction as compared to the market. If HUTCHMED DRC Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one HUTCHMED DRC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of HUTCHMED DRC is generally in the same direction as the market. If Beta > 1 HUTCHMED DRC moves generally in the same direction as, but more than the movement of the benchmark.
HUTCHMED DRC Thematic Clasifications
HUTCHMED DRC is part of several thematic ideas from Health Management to Cancer Fighters. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasHUTCHMED DRC November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of HUTCHMED DRC help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of HUTCHMED DRC. We use our internally-developed statistical techniques to arrive at the intrinsic value of HUTCHMED DRC based on widely used predictive technical indicators. In general, we focus on analyzing HUTCHMED Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build HUTCHMED DRC's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.76 | |||
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 12.71 | |||
| Value At Risk | (5.01) | |||
| Potential Upside | 5.32 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (0.25) | Revenue Per Share 3.575 | Quarterly Revenue Growth (0.43) | Return On Assets (0.06) |
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.